ANXA1 and inflammatory bowel disease: According to early studies of UC, one of the characteristics of an active episode of US is the intense mucosal infiltration of leukocytes, and the proresolution mediator ANXA1 exerts counterregulatory effects on leukocyte recruitment and exhibits elevated levels in sera isolated from active IBD patients (66).